Viewing Study NCT02866227


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-04-12 @ 4:27 AM
Study NCT ID: NCT02866227
Status: COMPLETED
Last Update Posted: 2018-03-09
First Post: 2016-07-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TOL-463 Phase 2 Study for Vaginitis
Sponsor: Toltec Pharmaceuticals, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module